Compounds > piracetam
Page last updated: 2024-08-16

piracetam and bortezomib

piracetam has been researched along with bortezomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bhattacharyya, S; Cai, X; Klein, JP; LaBuzetta, JN; Munshi, NC; Plitt, A; Raibagkar, P; Schleicher, SM1

Other Studies

2 other study(ies) available for piracetam and bortezomib

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Jan-10, Volume: 34, Issue:2

    Topics: Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents; Biomarkers, Tumor; Bortezomib; Brain; Disease Management; Disease Progression; Female; Humans; Immunoglobulin kappa-Chains; Levetiracetam; Magnetic Resonance Imaging; Middle Aged; Multiple Myeloma; Neurologic Examination; Nimodipine; Nootropic Agents; Oligopeptides; Piracetam; Polyneuropathies; Posterior Leukoencephalopathy Syndrome; Secondary Prevention; Seizures

2016